DSG Consumer Partners has announced its follow-on investment in Blood, leading the Series B funding round to strengthen the brand's growth in Southeast Asia's Femcare market.
Target Information
Blood is a pioneering brand dedicated to transforming the period care experience for women in Southeast Asia. Launched initially as PS Love, the company fervently supports women by offering high-quality, innovative products, including ultra-thin, rash-free pads and drug-free menstrual pain relief patches. With an emphasis on functionality combined with a customer-first approach, Blood has quickly become a trusted choice among Singaporean and Malaysian women.
Since its inception, Blood has exceeded expectations and established itself as a leader in the Femcare sector. Now, with added support from DSG Consumer Partners (DSGCP), Blood is set to elevate its reach and enhance its product offerings, aiming to empower millions more Southeast Asian women.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The Femcare industry in Southeast Asia is rapidly expanding as awareness and demand for quality menstrual products grow. In recent years, there has been a significant
Similar Deals
DSG Consumer Partners
invested in
Blood
in 2023
in a Series B deal